ADVERTISEMENT

Stocks To Watch: Cadila Healthcare, Dena Bank, Navin Flourine

SGX Nifty indicates a negative start to trade



A visitor views the electronic board displaying stock activity at the Brasil Bolsa Bacao (B3) stock exchange in Sao Paulo, Brazil. (Photographer: Patricia Monteiro/Bloomberg)
A visitor views the electronic board displaying stock activity at the Brasil Bolsa Bacao (B3) stock exchange in Sao Paulo, Brazil. (Photographer: Patricia Monteiro/Bloomberg)
  • Dena Bank plans Rs 1,800 crore fund raise via QIP
  • Promoters sell stake in Navin Flourine
  • Blackstone sells stake in Jagran Prakashan
  • Cadila receives U.S. FDA nod for Hepatitis B drug

The Singapore traded SGX Nifty, an early indicator of Nifty’s performance in India, fell 0.2 percent to 9,494.

Here are the stocks to watch out for in today’s session:

Navin Flourine

  • Promoter Mafatlal Industries and NOCIL sold their entire stake of 1.18 lakh shares (or 1.2 percent equity) and 4.71 lakh shares (or 4.8 percent equity) respectively at Rs 2,875 each
  • Goldman Sachs India Fund bought 68,886 shares or 0.7 percent stake at Rs 2,875 each
  • HSBC Global Investment Funds Asia ex-Japan bought 1.56 lakh shares or 1.6 percent stake at Rs 2,875 each
  • GMO Emerging Domestic Opportunities Fund Bought 1.57 lakh shares or 1.6 percent stake at Rs 2,875 each
  • GSA MGT bought 56,263 shares or 0.6 percent stake at Rs 2,875 each
  • Dena Bank: Shareholders approve to raise Rs 1,800 crore via QIP issue
  • Hero MotoCorp: LIC sold 2.03 percent stake in the company
  • Jagran Prakashan: Blackstone GPV sold its entire stake in Jagran Prakashan founder Jagran Media Network Investment Pvt. Ltd. (JMNIPL)
  • Cadila Healthcare: Received U.S. FDA nod for generic Hepatitis B drug
  • Federal Bank: Approves closure of its QIP and sets its issue price at Rs 116 per share
  • Raymond: To invest Rs 1,400 crore in its Amravati unit and open 300 new stores
  • Lupin, Dr. Reddy's Laboratories: Cannot market generic versions of Vimovo as New Jersey District Court upheld Horizon Pharma's patent. (Bloomberg)

Other Corporate Announcements

  • Indiabulls Real Estate: Acquires entire minority stake of 10.08 percent in Indiabulls Infraestate Ltd. (IIL) from IL&FS Fund entities for a total consideration of Rs 358.44 crore. With this IIL becomes the wholly-owned subsidiary of the company
  • Country Club: Board approves sale of assets for the purpose of debt reduction of the company
  • Omax Autos: Shuts down its manufacturing unit in Gurugram
  • HPCL: Considering issue of bonds in the overseas market

Today’s Nifty Call

Stocks To Watch: Cadila Healthcare, Dena Bank, Navin Flourine

Brokerage Calls

  • Aurobindo Pharma: Downgraded to 'Hold' at Sharekhan with price target of Rs 735
  • Firstsource Solutions: Raised to 'Buy' at SBI Capital Securities with price target of Rs 45
  • Supreme Industries: Downgraded to 'Hold' at Sharekhan with price target of Rs 1,250
  • Axis Bank: CLSA maintains 'Outperform' with price target of Rs 570

Bulk Deals

Arrow Greentech

  • Promoters sold 5 lakh shares or 4.3 percent stake at Rs 530 each
  • DSP Blackrock Mutual Fund bought 4.71 lakh shares or 4 percent stake at Rs 530 each

Tejas Networks

  • Abu Dhabhi Investments bought 5.3 lakh shares or 3.1 percent stake at Rs 265.12 each
  • Amansa Holdings Pvt. Ltd. bought 13.5 lakh shares or 7.9 percent stake at Rs 260.56 each

Stocks In F&O Ban

  • DLF
  • Fortis Healthcare
  • GMR Infrastructure
  • IndiaBulls Real Estate
  • IFCI
  • India Cements
  • Infibeam Incorporation
  • Jaiprakash Associates
  • Oriental Bank of Commerce
  • Reliance Communications
  • Reliance Capital
  • Ujjivan Financial Services

F&O Stocks To Watch

  • JP Associates: Sees short covering with open interest down 8 percent
  • AB Nuvo: Sees short covering with open interest down 21 percent
  • SBI: Sees fresh shorts with open interest up 9 percent
  • GMR Infrastructure: Sees long unwinding with open interest down 5 percent
  • Kaveri Seeds: Sees fresh longs with open interest up 18 percent
  • Rolls Higher Than 3-Month Average: HCL Tech and Mahindra & Mahindra
  • Rolls Lower Than 3-Month Average: Lupin and Vedanta

Media Reports

  • Cadila Healthcare: Aims to double U.S. business in three years. (Business Standard)
  • Ashok Leyland: To focus on commercial vehicles. (Business Standard)
  • Idea Cellular: Clarification sought by SEBI can delay merger with Vodafone. (Hindu Business Line)
  • Tata Group: Chairman N Chandrashekhar may outline plans to revitalise group this week. (Economic Times)
  • ABG Shipyard: Liberty House in talks to buyout the company. (Business Standard)